COMMUNIQUÉS West-GlobeNewswire

Kyverna Therapeutics Highlights Potential of KYV-101 in Multiple Sclerosis with Data from Phase 1 Investigator-Initiated Trials to be Presented at ECTRIMS
24/09/2025
KYV-101 IIT data demonstrate promising clinical activity, including robust CAR T penetration into the central nervous system (CNS) and improved expanded disability status scale scores (EDSS) KYV-101 continues to [...]
Hemp Hop Launches 3 High THCa Ice Water Hash and Iconic Flower Strains: October 2025
24/09/2025
CHARLOTTE, N.C., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Hemp Hop will be kicking off October 2025 with the launch of 3 new high THCa ice water hash concentrates and the return of 3 iconic strains of exotic THCa flower . [...]
New Data for BRIUMVI® Demonstrate 89.9% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 6 Years of Continuous BRIUMVI Treatment
24/09/2025
During year 6 of continuous treatment with BRIUMVI the annualized relapse rate was 0.012, equivalent to one relapse occurring every 83 years of patient treatment Overall safety profile of BRIUMVI remained consistent [...]
Vivani Medical to Present at the Emerging Growth Conference on September 25, 2025
24/09/2025
ALAMEDA, Calif., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, [...]
24/7 Market News: Kraig Labs Eco-Engineered Spider Silk Poised to Redefine Sports Apparel
24/09/2025
DENVER, Sept. 24, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com , a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that Kraig Biocraft Laboratories (OTCQB: [...]
Breakthrough San Diego Clinic Uses Cutting-Edge NUCCA Technique to Reverse Chronic Pain and Restore Quality of Life — Without Drugs or Surgery
24/09/2025
San Diego-based Origin Modern Health & Wellness uses powerful, gentle root cause care, reconnecting individuals to their body’s potential SAN DIEGO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- As millions of Americans [...]
Medicovestor, Inc. Wins First Place at the Next Star North America Biomedical Special Competition in Boston, part of the 2025 Entrepreneur Next Star Million Prize Global Challenge
24/09/2025
BOSTON, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Medicovestor, Inc., a biotechnology company pioneering next-generation antibody-drug conjugates (ADCs) for cancer treatment, announced today that it has been awarded First [...]
La Financière de Tubize renforce son expertise dans le domaine biopharma en nommant 2 nouvelles administratrices
24/09/2025
Depuis la nomination de Bruno Holthof comme président du conseil d'administration de la société en avril 2025, le conseil d’administration de la société poursuit le renforcement de son expertise dans le domaine [...]
Financière de Tubize strengthens its expertise in the biopharma field by appointing 2 new directors
24/09/2025
Since the appointment of Bruno Holthof as Chairman of the Board of Directors of the company in April 2025, the company's board has continued to strengthen its expertise in the biopharma field. This aims to best support [...]
Pluristyx and Solesis Announce Strategic Collaboration to Advance Organoid and Cell Therapy Solutions
24/09/2025
SEATTLE and TELFORD, Pa., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Pluristyx, Inc. and Solesis, LLC today announced the signing of a Memorandum of Understanding (MOU) establishing their strategic collaboration. The primary [...]
Scilex Holding Company Announces It Has Entered into a Memorandum of Understanding with Biconomy.com to Collaborate on Future Cryptocurrency Strategies and Treasury Management
24/09/2025
PALO ALTO, Calif., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]
The Association of American Physicians and Surgeons (AAPS) Supports Course Correction on Autism
24/09/2025
TUCSON, Ariz., Sept. 24, 2025 (GLOBE NEWSWIRE) -- In a joint appearance, President Donald Trump, HHS Secretary Robert F. Kennedy, Jr., NIH Director Jay Bhattacharya, FDA Commissioner Marty Makary, and CMS Director [...]
Zealand Pharma appoints Rachel James-Owens as Vice President, Corporate Communications & Media Relations
24/09/2025
Press release – No. 14 / 2025 Zealand Pharma appoints Rachel James-Owens as Vice President, Corporate Communications & Media Relations Copenhagen, Denmark, September 24, 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR [...]
Booking Health Expands Access to Stage 4 Cancer Treatment in Germany
24/09/2025
Langenfeld, Germany, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Booking Health , a leading medical travel facilitator, has announced the expansion of its oncology services to improve international access to advanced stage 4 [...]
EUROBIO SCIENTIFIC: RESULTS FOR THE FIRST SEMESTER OF FISCAL YEAR 2025
24/09/2025
RESULTS FOR THE FIRST SEMESTER OF FISCAL YEAR 2025 Revenue up 10% to €80.7 million Proprietary products account for 36% of revenue 42% of revenue generated outside France 2025 results impacted by the transfer of [...]
Eurobio Scientific : résultat du 1er semestre 2025
24/09/2025
RESULTAT DU 1 ER SEMESTRE 2025 Chiffre d’affaires en croissance de 10% à 80,7 M€ les produits propriétaires atteignent 36% du CA la part du CA hors France est de 42% Résultats 2025 impacté par le transfert de la [...]
Guerbet : Résultats semestriels 2025 : Chiffre d’affaires du 1er semestre : 387,8 M€, en retrait de 5,4% à TCC et périmètre comparable principalement en lien avec la baisse d’activité en France
24/09/2025
Résultats semestriels 2025 Activité et rentabilité Chiffre d’affaires du 1 er semestre : 387,8 M€, en retrait de 5,4% à TCC 1 et périmètre comparable 2 , principalement en lien avec la baisse d’activité en France La [...]
Guerbet : H1 2025 results : H1 revenue: €387.8 million, down 5.4% at CER and on a like-for-like basis, mainly due to the decline in activity in France
24/09/2025
H1 2025 results Activity and profitability H1 revenue: €387.8 million, down 5.4% at CER 1 and on a like-for-like basis 2 , mainly due to the decline in activity in France Restated EBITDA margin 3 came out at 12.9%, [...]
Sagimet Biosciences Announces Upcoming Panel Participation at Fierce Biotech Week
24/09/2025
SAN MATEO, Calif., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and [...]

Pages